Literature DB >> 19635635

Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota.

Constantine Tsigrelis1, Imad M Tleyjeh, Brian D Lahr, Lisa M Nyre, Abinash Virk, Larry M Baddour.   

Abstract

OBJECTIVE: Following the introduction of a 7-valent pneumococcal conjugate vaccine (PCV-7) for children in early 2000 in the United States, a decrease in the incidence of invasive pneumococcal disease (IPD) was seen in adults, likely due to a herd effect. However, there have been recent increases in IPD in adults caused by Streptococcus pneumoniae serotypes not included in PCV-7, so called "replacement disease". We performed a population-based study to further investigate this emerging concern.
METHODS: Population-based incidence study in Olmsted County, Minnesota, United States, in adults aged > or =50 years.
RESULTS: From 1/1/1995 to 12/31/2007, 104 cases of IPD were identified in Olmsted County in adults aged > or =50 years. We found a 45% increase in the incidence rate of IPD from 2001-2003 (17.7 cases per 100,000 person-years) to 2004-2007 (32.1 cases per 100,000 person-years) (p=0.029). From 2002-2004 to 2005-2007, the incidence rate of IPD caused by S. pneumoniae serotypes not included in PCV-7 increased from 9.2 to 32.8 cases per 100,000 person-years (p<0.001).
CONCLUSION: A recent increase in the incidence of IPD in adults aged > or =50 years was demonstrated in Olmsted County, Minnesota due to serotypes not found in PCV-7. These findings are unique and merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635635      PMCID: PMC2743782          DOI: 10.1016/j.jinf.2009.07.004

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  13 in total

1.  Pneumococcal vaccine--direct and indirect ("herd") effects.

Authors:  Daniel M Musher
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

2.  Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?

Authors:  Matthew R Moore; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

3.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

4.  Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

Authors:  Catherine A Lexau; Ruth Lynfield; Richard Danila; Tamara Pilishvili; Richard Facklam; Monica M Farley; Lee H Harrison; William Schaffner; Arthur Reingold; Nancy M Bennett; James Hadler; Paul R Cieslak; Cynthia G Whitney
Journal:  JAMA       Date:  2005-10-26       Impact factor: 56.272

5.  Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota.

Authors:  Imad M Tleyjeh; James M Steckelberg; Hani S Murad; Nandan S Anavekar; Hassan M K Ghomrawi; Zaur Mirzoyev; Sherif E Moustafa; Tanya L Hoskin; Jayawant N Mandrekar; Walter R Wilson; Larry M Baddour
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

6.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

7.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

8.  Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota.

Authors:  Daniel Z Uslan; Sarah J Crane; James M Steckelberg; Franklin R Cockerill; Jennifer L St Sauver; Walter R Wilson; Larry M Baddour
Journal:  Arch Intern Med       Date:  2007-04-23

9.  Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Authors:  Rochelle Lacapa; Sandra J Bliss; Francene Larzelere-Hinton; Kathryn J Eagle; Debra J McGinty; Alan J Parkinson; Mathuram Santosham; Mariddie J Craig; Katherine L O'Brien
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

10.  Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.

Authors:  W C Albrich; W Baughman; B Schmotzer; M M Farley
Journal:  Clin Infect Dis       Date:  2007-05-08       Impact factor: 9.079

View more
  2 in total

Review 1.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

2.  Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County, Minnesota.

Authors:  Constantine Tsigrelis; Imad M Tleyjeh; W Charles Huskins; Brian D Lahr; Lisa M Nyre; Abinash Virk; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.